AbBaltis launches new Blood Component Processing department
It processes plasma and serum to IVD developers' specifications, including delipidation and defibrination.
See the latest news and media coverage for AbBaltis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Supplier of disease state plasma and residual clinical samples
abbaltis.comLast updated
In short: AbBaltis expanded its operations by launching a new processing department and planning its first exhibition in the United States market.
It processes plasma and serum to IVD developers' specifications, including delipidation and defibrination.
The company has supplied disease-state plasma for 16 years and now enters the US market, showcasing at Booth #916.
The role is located in Borden, England, and applications are currently open
In April 2015, it received recognition as one of 105 British businesses for excellence in international trade. Managing Director attended Buckingham Palace reception and royal visit.
A supplier of blood plasma for scientific research which is exporting around the world. Based at Kent Science Park, it is growing turnover at 40...
Founded in 2010 by Giedre Brandao, AbBaltis is a biotechnology SME focused on advancing blood diagnostics and supporting the global scientific community. Beyond innovative diagnostics...
A biotech company that supplies blood plasma for lab testing is set to hit sales of £1million for the first time in 2020 after securing...
A small biological materials supplier is preparing its next wave of employees by launching a work experience programme. AbBaltis employs less than 10 people but...
Track AbBaltis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.